Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Unknown Primary × Epirubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Stomach Neoplasms 6 Esophageal Neoplasms 5 Inflammatory Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Adenocarcinoma Of Esophagus 2 Sarcoma 1 Neoplasms 1 Her2-Positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms, Male 1 Adenocarcinoma 1

Interventions

Paclitaxel 6 Carboplatin 6 Gemcitabine 3 Irinotecan 2 Erlotinib Hydrochloride 2 Capecitabine 2 Bevacizumab 2 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 entrectinib 1 cobimetinib 1 belinostat 1 atezolizumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Oxaliplatin 1 HhAntag691 1 Everolimus 1 Etoposide 1 Cisplatin 1 CP protocol 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡